LA JOLLA, CA--(Marketwire - February 05, 2008) - Transdel Pharmaceuticals, Inc. (OTCBB: TDLP), a specialty pharmaceutical company focused on the development and commercialization of non-invasive topically delivered medications, today announced that Dr. Juliet Singh, President and CEO, and John Lomoro, CFO, will host a conference call to update shareholders on the business developments that have taken place, which will be followed by a question and answer period.
